Výsledky vyhledávání - "Paolo Passannanti"

Lenvatinib and other tyrosine kinase inhibitors for the treatment of radioiodine refractory, advanced, and progressive thyroid cancer

Autor: Eleonora Molinaro, Salvatore Mazzeo, Laura Valerio, Elena Sabini, Agnese Biagini, Loredana Lorusso, Carlotta Giani, Valentina Battaglia, Paolo Passannanti, Benedetta Pontillo-Contillo, Rossella Elisei, Letizia Pieruzzi

Publikováno v: OncoTargets and therapy

Lenvatinib is a small oral molecule able to inhibit three of the extracellular and intracellular molecules involved in the modulation of angiogenesis and lymphangiogenesis: vascular endothelial growth factor receptor 1–3, fibroblast growth factor r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd129647694f5ef521b13fcd1fba0bac
http://hdl.handle.net/11568/840078

Zobrazit plný text záznamu

RET genetic screening of sporadic medullary thyroid cancer (MTC) allows the preclinical diagnosis of unsuspected gene carriers and the identification of a relevant percentage of hidden familial MTC (FMTC)

Autor: Agnese Biagini, David Viola, Paolo Passannanti, Fulvio Basolo, Aldo Pinchera, Clara Ugolini, Gabriele Materazzi, Valeria Bottici, Rossella Elisei, Barbara Cosci, Cristina Romei, G. Renzini, Paolo Vitti, Eleonora Molinaro, Laura Agate

Publikováno v: Clinical Endocrinology. 74:241-247

Summary Objective This study was aimed to demonstrate the clinical benefits of rearranged during transfection (RET) genetic screening in patients with apparently sporadic medullary thyroid cancer (MTC) not only to identify the hereditary nature of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::53dedee5d5eb20497659b334a29fa95e
https://doi.org/10.1111/j.1365-2265.2010.03900.x